Precision medicine in Sjögren's disease
- 6 May 2024
- journal article
- review article
- Published by Elsevier in The Lancet Rheumatology
- Vol. 6 (9) , e636-e647
Abstract
No abstract availableKeywords
Funding Information
- Servier
This publication has 75 references indexed in Scilit:
- Efficacy and Safety of Low-Dose Interleukin 2 for Primary Sjögren SyndromeJAMA Network Open, 2022
- Ectopic Germinal Center–Like Structures in Minor Salivary Gland Biopsy Tissue Predict Lymphoma Occurrence in Patients With Primary Sjögren's SyndromeArthritis & Rheumatology, 2018
- Attenuation of Follicular Helper T Cell–Dependent B Cell Hyperactivity by Abatacept Treatment in Primary Sjögren's SyndromeArthritis & Rheumatology, 2017
- Genome‐Wide Association Analysis Reveals Genetic Heterogeneity of Sjögren's Syndrome According to AncestryArthritis & Rheumatology, 2017
- Rheumatoid Factor and Disease Activity Are Independent Predictors of Lymphoma in Primary Sjögren's SyndromeArthritis & Rheumatology, 2015
- Pain Severity and Neuropathic Pain Symptoms in Primary Sjögren's Syndrome: A Comparison Study of Seropositive and Seronegative Sjögren's Syndrome PatientsArthritis Care & Research, 2013
- Clinical and histologic evidence of salivary gland restoration supports the efficacy of rituximab treatment in Sjögren's syndromeArthritis & Rheumatism, 2009
- BAFF‐modulated repopulation of B lymphocytes in the blood and salivary glands of RITUXIMAB‐TREATED patients with Sjögren's syndromeArthritis & Rheumatism, 2007
- Improvement of Sjögren's syndrome after two infusions of rituximab (anti‐CD20)Arthritis Care & Research, 2007
- Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross‐reactive idiotypes as predictive factors for the development of lymphoma in primary Sjögren's syndromeArthritis & Rheumatism, 1996